Moderate dose escalation with single-fraction high-dose-rate brachytherapy boost for clinically localized intermediate- and high-risk prostate cancer: 5-year outcome of the first 100 consecutively treated patients

Péter Ágoston, Tibor Major, Georgina Fröhlich, Zoltán Szabó, József Lövey, János Fodor, Miklós Kásler, Csaba Polgár

Research output: Contribution to journalArticle

33 Citations (Scopus)

Fingerprint Dive into the research topics of 'Moderate dose escalation with single-fraction high-dose-rate brachytherapy boost for clinically localized intermediate- and high-risk prostate cancer: 5-year outcome of the first 100 consecutively treated patients'. Together they form a unique fingerprint.

Medicine & Life Sciences